BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38758553)

  • 1. Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer.
    Rinder P; Marcille T; Sinel-Boucher P; Cals-Maurette M; Kanoun D; Levy C; Teixeira L; Hornus P; Szeftel D; Heudel PE
    JAMA Netw Open; 2024 May; 7(5):e2411909. PubMed ID: 38758553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
    Yen L; Wu J; Hodgkins PL; Cohen RD; Nichol MB
    J Manag Care Pharm; 2012; 18(9):701-12. PubMed ID: 23206213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation.
    Wirbka L; Ruff C; Haefeli WE; Meid AD
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1161-1172. PubMed ID: 36125062
    [No Abstract]   [Full Text] [Related]  

  • 4. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
    Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy use among Appalachian breast cancer survivors.
    Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
    Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data.
    Lailler G; Memoli V; Le Bihan Benjamin C; Ben Diane MK; Lauzier S; Mancini J; Bousquet PJ; Bouhnik AD
    Clin Breast Cancer; 2021 Aug; 21(4):e415-e426. PubMed ID: 33745868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
    Neugut AI; Subar M; Wilde ET; Stratton S; Brouse CH; Hillyer GC; Grann VR; Hershman DL
    J Clin Oncol; 2011 Jun; 29(18):2534-42. PubMed ID: 21606426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Newly Prescribed Diabetes Medications Among Insured Latino and White Patients With Diabetes.
    Fernández A; Quan J; Moffet H; Parker MM; Schillinger D; Karter AJ
    JAMA Intern Med; 2017 Mar; 177(3):371-379. PubMed ID: 28114642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration.
    Okada M; Wong TY; Mitchell P; Eldem B; Talks SJ; Aslam T; Daien V; Rodriguez FJ; Gale R; Barratt J; Finger RP; Loewenstein A
    JAMA Ophthalmol; 2021 Jul; 139(7):769-776. PubMed ID: 34081099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of including early nonadherence in estimations of medication adherence.
    Raebel MA; Carroll NM; Ellis JL; Schroeder EB; Bayliss EA
    Ann Pharmacother; 2011 Sep; 45(9):1053-60. PubMed ID: 21852598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer.
    Neugut AI; Zhong X; Wright JD; Accordino M; Yang J; Hershman DL
    JAMA Oncol; 2016 Oct; 2(10):1326-1332. PubMed ID: 27281650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review.
    Okada M; Mitchell P; Finger RP; Eldem B; Talks SJ; Hirst C; Paladini L; Barratt J; Wong TY; Loewenstein A
    Ophthalmology; 2021 Feb; 128(2):234-247. PubMed ID: 32763265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System.
    Hui RL; Adams AL; Niu F; Ettinger B; Yi DK; Chandra M; Lo JC
    J Manag Care Spec Pharm; 2017 Apr; 23(4):503-512. PubMed ID: 28345435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing adherence and persistence across 6 chronic medication classes.
    Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
    J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy.
    Chan A; Low XH; Yap KY
    J Manag Care Pharm; 2012 Jun; 18(5):385-94. PubMed ID: 22663171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
    Calip GS; Elmore JG; Boudreau DM
    Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
    Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
    Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry.
    Stanton AL; Petrie KJ; Partridge AH
    Breast Cancer Res Treat; 2014 Jun; 145(2):525-34. PubMed ID: 24781972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
    Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
    J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.